This badge represents independent contributors who have consistently met NewsBreak's standards for quality, along with adhering to policies, requirements, and editorial guidelines.

newsbreak_contributor

This badge represents contributors who have consistently met NewsBreak's standards for quality, along with adhering to all policies, requirements, and editorial guidelines.

certified_community_voice

Natalie Frank, Ph.D.

A recently published study in the New England Journal of Medicine, demonstrated that a gene therapy named LentiGlobin may provide a long lasting if not permanent cure for sickle cell disease.

NewsBreak Original

New Gene Therapy May Reverse Effects of Sickle Cell Disease

Related Contributors

Related Contributors